These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 34538522)

  • 1. Meeting report: Virtual Global Forum on Tuberculosis Vaccines, 20-22 April 2021.
    Suliman S; Pelzer PT; Shaku M; Rozot V; Mendelsohn SC
    Vaccine; 2021 Dec; 39(50):7223-7229. PubMed ID: 34538522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meeting report: 5th Global Forum on TB Vaccines, 20-23 February 2018, New Delhi India.
    Atmakuri K; Penn-Nicholson A; Tanner R; Dockrell HM
    Tuberculosis (Edinb); 2018 Dec; 113():55-64. PubMed ID: 30514514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in the development of new vaccines for tuberculosis and Brazil's role in the effort forward the end TB strategy.
    Junqueira-Kipnis AP; Leite LCC; Croda J; Chimara E; Carvalho ACC; Arcêncio RA
    Mem Inst Oswaldo Cruz; 2024; 119():e240093. PubMed ID: 39383403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel approaches to preclinical research and TB vaccine development.
    Walker KB; Guo M; Guo Y; Poecheim J; Velmurugan K; Schrager LK
    Tuberculosis (Edinb); 2016 Aug; 99 Suppl 1():S12-5. PubMed ID: 27452413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tuberculosis vaccines in the era of Covid-19 - what is taking us so long?
    Dockrell HM; McShane H
    EBioMedicine; 2022 May; 79():103993. PubMed ID: 35427852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiologic studies and novel clinical research approaches that impact TB vaccine development.
    Evans TG; Churchyard GJ; Penn-Nicholson A; Chen C; Gao X; Tait DR; Hatherill M
    Tuberculosis (Edinb); 2016 Aug; 99 Suppl 1():S21-5. PubMed ID: 27461190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tuberculosis vaccines update: Is an RNA-based vaccine feasible for tuberculosis?
    Larsen SE; Baldwin SL; Coler RN
    Int J Infect Dis; 2023 May; 130 Suppl 1():S47-S51. PubMed ID: 36963657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advocacy, partnership and political commitment for TB vaccine research.
    Olesen OF; Chan S; Chappell J; Guo Y; Leite LC
    Tuberculosis (Edinb); 2016 Aug; 99 Suppl 1():S26-9. PubMed ID: 27402313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Research Advances for Virus-vectored Tuberculosis Vaccines and Latest Findings on Tuberculosis Vaccine Development.
    Hu Z; Lu SH; Lowrie DB; Fan XY
    Front Immunol; 2022; 13():895020. PubMed ID: 35812383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TB vaccines in clinical development.
    Ginsberg AM; Ruhwald M; Mearns H; McShane H
    Tuberculosis (Edinb); 2016 Aug; 99 Suppl 1():S16-20. PubMed ID: 27470538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What's Old and New in Tuberculosis Vaccines for Children.
    Cranmer LM; Cotton MF; Day CL; Nemes E
    J Pediatric Infect Dis Soc; 2022 Oct; 11(Supplement_3):S110-S116. PubMed ID: 36314550
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Jia Q; Masleša-Galić S; Nava S; Horwitz MA
    mBio; 2022 Jun; 13(3):e0068722. PubMed ID: 35642945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TB biomarkers, TB correlates and human challenge models: New tools for improving assessment of new TB vaccines.
    Kaufmann SH; Fortune S; Pepponi I; Ruhwald M; Schrager LK; Ottenhoff TH
    Tuberculosis (Edinb); 2016 Aug; 99 Suppl 1():S8-S11. PubMed ID: 27402312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel vaccination strategies against tuberculosis.
    Andersen P; Kaufmann SH
    Cold Spring Harb Perspect Med; 2014 Jun; 4(6):. PubMed ID: 24890836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccines against tuberculosis: where are we and where do we need to go?
    Ottenhoff TH; Kaufmann SH
    PLoS Pathog; 2012; 8(5):e1002607. PubMed ID: 22589713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Towards building a tuberculosis free world.
    Mandal S
    Indian J Tuberc; 2022 Jul; 69(3):259-261. PubMed ID: 35760473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accelerating research and development of new vaccines against tuberculosis: a global roadmap.
    Cobelens F; Suri RK; Helinski M; Makanga M; Weinberg AL; Schaffmeister B; Deege F; Hatherill M;
    Lancet Infect Dis; 2022 Apr; 22(4):e108-e120. PubMed ID: 35240041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conference report: WHO meeting summary on mRNA-based tuberculosis vaccine development.
    Looney MM; Hatherill M; Musvosvi M; Flynn J; Kagina BM; Frick M; Kafuko Z; Schmidt A; Southern J; Wilder-Smith A; Tippoo P; Paradkar V; Popadić D; Scriba TJ; Hanekom W; Giersing B
    Vaccine; 2023 Nov; 41(48):7060-7066. PubMed ID: 37872013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The TB vaccine development pathway - An innovative approach to accelerating global TB vaccine development.
    Roordink D; Williams A; Fritzell B; Laddy DJ; Gerdil E; Graffin AM; Tait D; van der Pol L; van den Brink I; Holleman M; Thole J; Voss G; Lempicki M; Thiry G
    Tuberculosis (Edinb); 2021 Jan; 126():102040. PubMed ID: 33310626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccine development against tuberculosis before and after Covid-19.
    Kaufmann SHE
    Front Immunol; 2023; 14():1273938. PubMed ID: 38035095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.